Cargando…
P384: LOW CD19-MFI IN BALL CELLS BEFORE CAR T INFUSION PREDICTED A GOOD RESPONSE AND LONGER MRD-NEGATIVE MAINTENANCE TIME
Autores principales: | Wang, Ping, Deng, Xiaojuan, Zhang, Yun, LI, Yi, Du, Yuxuan, Peng, Xiangui, Zhang, Cheng, Feng, Yimei, Zhang, XI |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428267/ http://dx.doi.org/10.1097/01.HS9.0000968444.12608.d8 |
Ejemplares similares
-
MRD-Negative Remission Induced in EP300-ZNF384 Positive B-ALL Patients by Tandem CD19/CD22 CAR T-Cell Therapy Bridging to Allogeneic Stem Cell Transplantation
por: Zhang, Xin-Yue, et al.
Publicado: (2021) -
P1402: INFUSION OF 14 DAYS BLINATUNOMAB IN COMBINATION WITH CHEMOTHERAPY FOR 46-DAY MRD+ PEDIATRIC B-ALL PATIENTS IN INTERMEDIATE/HIGH-RISK GROUP RESULTS IN MRD CONVERSION.
por: Xue, Changwen, et al.
Publicado: (2023) -
Prognostic value of early bone marrow MRD status in CAR-T therapy for myeloma
por: Bansal, Radhika, et al.
Publicado: (2023) -
Uniform hierarchical MFI nanosheets prepared via anisotropic etching for solution-based sub–100-nm-thick oriented MFI layer fabrication
por: Liu, Yi, et al.
Publicado: (2020) -
Utility of flow cytometry screening before MRD testing in multiple myeloma
por: Panakkal, Vandana, et al.
Publicado: (2023)